HOTH insider filings
Hoth Therapeutics, Inc. — 19 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2025-08-28. Screen HOTH transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for HOTH between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — Hoth Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-08-28 | 4 | Knie Robb — CEO and President, Director | Grant/award (A): 800,000 @ $0 · Tax withholding (F): 310,744 @ $1.21 | EDGAR |
| 2025-01-15 | 4 | Springer Graig — Director | Grant/award (A): 70,000 (derivative) @ $0 | EDGAR |
| 2025-01-15 | 4 | Knie Robb — CEO and President, Director | Grant/award (A): 93,000 (derivative) @ $0 · Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2024-08-21 | 4 | Pavell Jeff — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-08-21 | 4 | Linsley Wayne — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-08-21 | 4 | Springer Graig — Director | Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 48,000 (derivative) @ $0 | EDGAR |
| 2024-08-21 | 4 | Sarnoff David — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-08-21 | 4 | Knie Robb — CEO and President, Director | Grant/award (A): 325,000 (derivative) @ $0 | EDGAR |
| 2024-08-19 | 4 | Knie Robb — CEO and President, Director | Purchase (P): 25,000 @ $0.67 | EDGAR |
| 2024-01-08 | 4 | Springer Graig — Director | Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2024-01-08 | 4 | Sarnoff David — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-01-08 | 4 | Pavell Jeff — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-01-08 | 4 | Linsley Wayne — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-01-08 | 4 | Knie Robb — CEO and President, Director | Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2023-07-18 | 4 | Linsley Wayne — Director | Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2023-07-18 | 4 | Sarnoff David — Director | Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2023-07-18 | 4 | Springer Graig — Director | Grant/award (A): 7,500 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2023-07-18 | 4 | Pavell Jeff — Director | Grant/award (A): 7,500 (derivative) @ $0 | EDGAR |
| 2023-07-18 | 4 | Knie Robb — CEO and President, Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Hoth Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-25 | 8-K | ? 8.01 — Other Events | EDGAR |
| 2026-09-22 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-11 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events | EDGAR |
| 2026-07-31 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-21 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-25 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-03 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-03 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-02 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-28 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=HOTH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →